Literature DB >> 12225374

The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype.

Maaike M B W Dooper1, Lianne Wassink, Laura M'Rabet, Yvo M F Graus.   

Abstract

The production of inflammatory mediators, relevant to (auto)immune diseases and chronic inflammatory conditions, can be modulated by dietary intake of n-3 and n-6 long chain polyunsaturated fatty acids (PUFAs). It was suggested that these effects are related to the formation of different series of eicosanoids, in particular prostaglandin-E (PGE). In this study we investigated whether prostaglandin subtypes metabolized from arachidonic acid (PGE2), dihomo-gamma-linolenic acid (PGE1) or eicosapentaenoic acid (PGE3) have different effects on T-cell proliferation and cytokine production in vitro. Freshly isolated human peripheral blood mononuclear cells (PBMC) were stimulated with concanavalin A (ConA) or lipopolysaccharide (LPS) in the presence or absence of exogenous PGE1, PGE2 or PGE3. We found that tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and to a lesser extent interleukin (IL)-10 production was inhibited by all PGE-subtypes in ConA-stimulated PBMC concomitant with unaffected IL-2 levels. The modulated cytokine production of ConA stimulated cells was independent of T-cell proliferation. PGE2 and PGE1 moderately stimulated proliferation, while PGE3 inhibited the proliferative response to some extent. In LPS-stimulated PBMC, TNF-alpha production was inhibited by all PGE-subtypes, whereas IL-6 remained unaffected and IL-10 production was increased. Time course experiments on the effects of PGE-subtypes on cytokine production after ConA or LPS stimulation showed these effects to be time dependent, but indifferent of the prostaglandin subtype added. Overall, the modulatory effects of PGE on cytokine production were irrespective of the subtype. This may implicate that the immunomodulatory effects of PUFAs, with respect to cytokine production, are not caused by a shift in the subtype of PGE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225374      PMCID: PMC1782765          DOI: 10.1046/j.1365-2567.2002.01474.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  61 in total

1.  Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery.

Authors:  W S Swails; A S Kenler; D F Driscoll; S J DeMichele; T J Babineau; T Utsunamiya; S Chavali; R A Forse; B R Bistrian
Journal:  JPEN J Parenter Enteral Nutr       Date:  1997 Sep-Oct       Impact factor: 4.016

2.  Sir David Cuthbertson Medal Lecture. Immunomodulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids.

Authors:  P C Calder
Journal:  Proc Nutr Soc       Date:  1996-07       Impact factor: 6.297

3.  gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial.

Authors:  R B Zurier; R G Rossetti; E W Jacobson; D M DeMarco; N Y Liu; J E Temming; B M White; M Laposata
Journal:  Arthritis Rheum       Date:  1996-11

4.  Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide.

Authors:  A R Amin; M Attur; R N Patel; G D Thakker; P J Marshall; J Rediske; S A Stuchin; I R Patel; S B Abramson
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

5.  Calcium signaling restitution prevents T-cell proliferative suppression by prostaglandin E2.

Authors:  M A Choudhry; M M Sayeed
Journal:  Shock       Date:  1996-08       Impact factor: 3.454

6.  Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production.

Authors:  I Tsuboi; H Tanaka; M Nakao; S Shichijo; K Itoh
Journal:  Cytokine       Date:  1995-05       Impact factor: 3.861

7.  Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T cells.

Authors:  C M Hilkens; A Snijders; H Vermeulen; P H van der Meide; E A Wierenga; M L Kapsenberg
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

8.  Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10.

Authors:  S Poole; F Q Cunha; S Selkirk; B B Lorenzetti; S H Ferreira
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

9.  The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil.

Authors:  G E Caughey; E Mantzioris; R A Gibson; L G Cleland; M J James
Journal:  Am J Clin Nutr       Date:  1996-01       Impact factor: 7.045

10.  Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.

Authors:  T C van der Pouw Kraan; L C Boeije; R J Smeenk; J Wijdenes; L A Aarden
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  22 in total

1.  Associations of cord blood fatty acids with lymphocyte proliferation, IL-13, and IFN-gamma.

Authors:  Diane R Gold; Ben M Willwerth; Kelan G Tantisira; Patricia W Finn; Bianca Schaub; David L Perkins; Arthur Tzianabos; Ngoc P Ly; Christian Schroeter; Fiona Gibbons; Hannia Campos; Emily Oken; Matthew W Gillman; Lyle J Palmer; Louise M Ryan; Scott T Weiss
Journal:  J Allergy Clin Immunol       Date:  2006-02-14       Impact factor: 10.793

Review 2.  The role of fish oils in the treatment of rheumatoid arthritis.

Authors:  Leslie G Cleland; Michael J James; Susanna M Proudman
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals.

Authors:  Shinichiro Inaba; Shunji Nagahara; Naoki Makita; Yuzo Tarumi; Takuji Ishimoto; Seiichi Matsuo; Kenji Kadomatsu; Yoshifumi Takei
Journal:  Mol Ther       Date:  2011-10-25       Impact factor: 11.454

4.  E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.

Authors:  Mitsuhiro Okano; Yuji Sugata; Tazuko Fujiwara; Rie Matsumoto; Masahiro Nishibori; Kenji Shimizu; Megumi Maeda; Yoshinobu Kimura; Shin Kariya; Hisashi Hattori; Minehiko Yokoyama; Kosuke Kino; Kazunori Nishizaki
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

5.  High expression levels of macrophage migration inhibitory factor sustain the innate immune responses of neonates.

Authors:  Thierry Roger; Anina Schneider; Manuela Weier; Fred C G J Sweep; Didier Le Roy; Jürgen Bernhagen; Thierry Calandra; Eric Giannoni
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

6.  Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts.

Authors:  L E M Willemsen; M A Koetsier; S J H van Deventer; E A F van Tol
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

7.  Oral administration of dihomo-gamma-linolenic acid prevents development of atopic dermatitis in NC/Nga mice.

Authors:  H Kawashima; N Tateishi; A Shiraishi; N Teraoka; T Tanaka; A Tanaka; H Matsuda; Y Kiso
Journal:  Lipids       Date:  2007-11-06       Impact factor: 1.880

8.  Eicosapentaenoic acid suppression of systemic inflammatory responses and inverse up-regulation of 15-deoxyΔ(12,14) prostaglandin J2 production.

Authors:  Jillian Davidson; Warren Higgs; Dino Rotondo
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

9.  Dihomo-gamma-linolenic acid inhibits tumour necrosis factor-alpha production by human leucocytes independently of cyclooxygenase activity.

Authors:  Maaike M B W Dooper; Boet van Riel; Yvo M F Graus; Laura M'Rabet
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

10.  Polyunsaturated fatty acids support epithelial barrier integrity and reduce IL-4 mediated permeability in vitro.

Authors:  Linette E M Willemsen; Marleen A Koetsier; Martin Balvers; Christopher Beermann; Bernd Stahl; Eric A F van Tol
Journal:  Eur J Nutr       Date:  2008-05-22       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.